MYOS CORPORATION – Trademark Portfolio
Entity Type: 03
MYOS CORPORATION holds 28 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 26 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include MYOS, FORTETROPIN, and PHYSICIAN MUSCLE HEALTH FORMULA. The owner is based in CEDAR KNOLLS, NJ.
45 HORSEHILL ROAD
CEDAR KNOLLS, NJ 07927
Showing of trademarks Trademarks
Trademark Classifications
MYOS CORPORATION's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Education; providing of training; entertainment; sporting and cultural activities
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does MYOS CORPORATION have?
MYOS CORPORATION has 28 U.S. trademarks filed with the USPTO. Of these, 3 registered, 20 abandoned, 5 cancelled.
What trademark classes does MYOS CORPORATION file in?
MYOS CORPORATION files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 41 (Education & Entertainment), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are MYOS CORPORATION's most well-known trademarks?
MYOS CORPORATION's registered trademark portfolio includes well-known marks such as MYOS, FORTETROPIN, and PHYSICIAN MUSCLE HEALTH FORMULA. These are among 3 currently registered trademarks in the portfolio.
What is MYOS CORPORATION's trademark registration success rate?
MYOS CORPORATION has a 11% trademark registration rate, with 3 out of 28 resolved applications resulting in successful registration. Currently, 0 applications are pending review.